Slingshot members are tracking this event:
Regeneron (REGN) and Sanofi's (SNY) Sarilumab Approved in Canada for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA)
Slingshot Insights Explained
Feb 01, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Sarilumab, Canada, Health Canada, Adult Patients, Moderately To Severely Active, Rheumatoid Arthritis, Ra